Influence of age on the clinical differentiation of atypical pneumonia in adults

Respirology

Volumn 17, Issue 7, 2012, Pages 1073-1079

  Miyashita, Naoyuki ^a   Kawai, Yasuhiro ^a   Akaike, Hiroto ^a   Ouchi, Kazunobu ^a   Hayashi, Toshikiyo ^a   Kurihara, Takeyuki ^a   Okimoto, Niro ^a  

^a KAWASAKI MEDICAL SCHOOL   (Japan)

Author keywords

atypical pneumonia; clinical differentiation; community acquired pneumonia; elderly; Japanese Respiratory Society scoring system

Indexed keywords

BETA LACTAM ANTIBIOTIC; MACROLIDE; MINOCYCLINE; QUINOLONE DERIVATIVE;

ADULT; AGE; AGED; ARTICLE; BACTERIAL PNEUMONIA; CHLAMYDIAL PNEUMONIA; CHLAMYDOPHILA PNEUMONIAE; CLINICAL PRACTICE; COMMUNITY ACQUIRED PNEUMONIA; COMORBIDITY; CONTROLLED STUDY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; HAEMOPHILUS INFECTION; HUMAN; JAPANESE RESPIRATORY SOCIETY SCORING SYSTEM; LEGIONELLA PNEUMOPHILA; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; MORAXELLA CATARRHALIS; MYCOPLASMA PNEUMONIA; MYCOPLASMA PNEUMONIAE; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; SEROLOGY; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS PNEUMONIAE; VIRUS PNEUMONIA;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CHLAMYDOPHILA PNEUMONIAE; COMMUNITY-ACQUIRED INFECTIONS; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; JAPAN; MALE; MIDDLE AGED; MYCOPLASMA PNEUMONIAE; PNEUMONIA, BACTERIAL; PNEUMONIA, MYCOPLASMA; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 84866650972     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/j.1440-1843.2012.02188.x     Document Type: Article

References (19)

1. Arnold FW, Summersgill JT, Lajoie AS, et al,. A worldwide perspective of atypical pathogens in community-acquired pneumonia. Am. J. Respir. Crit. Care Med. 2007; 175: 1086-93.
2. Miyashita N, Fukano H, Mouri K, et al,. Community-acquired pneumonia in Japan: a prospective ambulatory and hospitalized patient study. J. Med. Microbiol. 2005; 54: 395-400.
3. The Committee for the Japanese Respiratory Society Guidelines in Management of Respiratory Infections. The Japanese Respiratory Society guideline for the management of community-acquired pneumonia in adults. Respirology 2006; 11: S1-S133.
4. Mandell LA, Wunderink RG, Anzueto A, et al,. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin. Infect. Dis. 2007; 44: S27-S72.
5. Morozumi M, Takahashi T, Ubukata K,. Macrolide-resistant Mycoplasma pneumoniae: characteristics of isolates and clinical aspects of community-acquired pneumonia. J. Infect. Chemother. 2010; 16: 78-86.
6. Miyashita N, Kawai Y, Yamaguchi T, et al,. Macrolide-resistant Mycoplasma pneumoniae in adults with community-acquired pneumonia. Int. J. Antimicrob. Agents 2010; 36: 384-5.
7. Miyashita N, Fukano H, Yoshida K, et al,. Is it possible to distinguish between atypical pneumonia and bacterial pneumonia?: evaluation of the guidelines for community-acquired pneumonia in Japan. Respir. Med. 2004; 98: 952-60.
8. Ishida T, Miyashita N, Nakahama C,. Clinical differentiation of atypical pneumonia using Japanese guidelines. Respirology 2007; 12: 104-10.
9. Miyashita N, Kawai Y, Yamaguchi T, et al,. Clinical potential of diagnostic methods for the rapid diagnosis of Mycoplasma pneumoniae pneumonia in adults. Eur. J. Clin. Microbiol. Infect. Dis. 2011; 30: 439-46.
10. Miyashita N, Fukano H, Okimoto N, et al,. Clinical presentation of community-acquired Chlamydia pneumoniae pneumonia in adults. Chest 2002; 121: 1776-81.
11. Miyashita N, Obase Y, Ouchi K, et al,. Clinical features of severe Mycoplasma pneumoniae pneumonia in adults admitted to an intensive care unit. J. Med. Microbiol. 2007; 56: 1625-9.
12. Hanley JA, McNeil BJ,. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982; 143: 29-36.
13. Marrie TJ,. Mycoplasma pneumoniae pneumonia requiring hospitalization, with emphasis on infection in the elderly. Arch. Intern. Med. 1993; 153: 488-94.
14. Metlay JP, Schulz R, Li YH, et al,. Influence of age on symptoms at presentation in patients with community-acquired pneumonia. Arch. Intern. Med. 1997; 157: 1453-9.
15. Niki Y, Hanaki H, Matsumoto T, et al,. Nationwide surveillance of bacterial respiratory pathogens conducted by the Japanese Society of Chemotherapy in 2008: general view of the pathogens' antibacterial susceptibility. J. Infect. Chemother. 2011; 17: 510-23.
16. Song JH, Jung SI, Ko KS, et al,. High prevalence of antimicrobial resistance among clinical Streptococcus pneumoniae isolates in Asia (an ANSORP study). Antimicrob. Agents Chemother. 2004; 48: 2101-7.
17. Inoue M, Lee NY, Hong SW, et al,. PROTEKT 1999-2000: a multicentre study of the antibiotic susceptibility of respiratory tract pathogens in Hong Kong, Japan and South Korea. Int. J. Antimicrob. Agents 2004; 23: 44-51.
18. Yokota S, Sato K, Yoshida S, et al,. Molecular epidemiology of fluoroquinolone-resistant Streptococcus pneumoniae in Japan. Kansenshogaku Zasshi 2004; 78: 428-34. (in Japanese).
19. Yokota S, Ohkoshi Y, Sato K, et al,. Emergence of fluoroquinolone- resistant Haemophilus influenzae strains among elderly patients but not among children. J. Clin. Microbiol. 2008; 46: 361-5.